A new treatment paradigm for POAG?

Article

Managing neuroinflammation could represent a promising new therapeutic approach in glaucoma

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Related Content
Audience listens lecturer at workshop. Concept image for ESCRS industry presentations by Ziemer Ophthalmic Systems, Heidelberg Engineering, STAR Surgical. (Image credit: ©Anton Gvozdikov/AdobeStock)

Heidelberg, STAAR, Ziemer to showcase latest technologies at ESCRS 2025

Kassi Filkins
September 13th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

September 13th 2025
Podcast
Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Kassi Filkins
September 13th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

September 13th 2025
Podcast
A photo of Prithvi Ramtohul, MD, who received the Ramin Tadayoni Award at the 2025 EURETINA Congress.

EURETINA grants Prithvi Ramtohul, MD, 2025 Ramin Tadayoni Award

Hattie Hayes
September 13th 2025
Article
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

Sydney M Crago
September 13th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.